Hwanin Pharmaceutical Reports 7.2 Billion KRW Operating Profit in 1Q, Down 20% YoY
[Asia Economy Reporter Minwoo Lee] Hwanin Pharm announced on the 27th that it posted provisional results for the first quarter of this year with consolidated sales of 42 billion KRW and operating profit of 7.2 billion KRW. Compared to the same period last year, sales increased by 7.0%, but operating profit decreased by 19.9%. Net profit for the same period was recorded at 6.4 billion KRW, down 16.2%.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Seongdong Police Station Chief Placed on Standby for Misuse of Official Vehicle... National Police Agency Launches Audit
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
